Annual Non Current Assets
$1.41 M
+$85.70 K+6.49%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual long term assets is $1.41 million, with the most recent change of +$85.70 thousand (+6.49%) on September 30, 2024.
- During the last 3 years, OTLK annual non current assets has risen by +$103.80 thousand (+7.96%).
- OTLK annual non current assets is now -92.91% below its all-time high of $19.84 million, reached on September 30, 2014.
Performance
OTLK Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$1.41 M
-$67.00 K-4.55%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly long term assets is $1.41 million, with the most recent change of -$67.00 thousand (-4.55%) on September 1, 2024.
- Over the past year, OTLK quarterly non current assets has increased by +$111.30 thousand (+8.59%).
- OTLK quarterly non current assets is now -93.28% below its all-time high of $20.95 million, reached on June 30, 2018.
Performance
OTLK Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
OTLK Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.5% | +8.6% |
| 3 y3 years | +8.0% | +8.0% |
| 5 y5 years | -61.3% | -61.8% |
OTLK Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.7% | -4.5% | +44.8% |
| 5 y | 5-year | -61.3% | +39.7% | -63.8% | +44.8% |
| alltime | all time | -92.9% | +39.7% | -93.3% | +44.8% |
Outlook Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $27.42 M(-11.5%) | - |
| Sep 2024 | - | $1.41 M(-4.5%) |
| Jun 2024 | - | $1.47 M(+18.6%) |
| Mar 2024 | - | $1.24 M(-4.1%) |
| Dec 2023 | - | $1.30 M(-1.9%) |
| Sep 2023 | $30.98 M(+12.6%) | $1.32 M(-7.5%) |
| Jun 2023 | - | $1.43 M(+47.0%) |
| Mar 2023 | - | $971.90 K(-4.0%) |
| Dec 2022 | - | $1.01 M(+0.5%) |
| Sep 2022 | $27.52 M(+28.0%) | $1.01 M(-6.2%) |
| Jun 2022 | - | $1.07 M(-5.7%) |
| Mar 2022 | - | $1.14 M(-5.9%) |
| Dec 2021 | - | $1.21 M(-7.1%) |
| Sep 2021 | $21.51 M(+19.9%) | $1.30 M(+32.4%) |
| Jun 2021 | - | $984.70 K(-25.3%) |
| Mar 2021 | - | $1.32 M(-11.3%) |
| Dec 2020 | - | $1.49 M(-16.9%) |
| Sep 2020 | $17.94 M | $1.79 M(-10.9%) |
| Jun 2020 | - | $2.01 M(-45.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.68 M(-5.1%) |
| Dec 2019 | - | $3.88 M(+6.8%) |
| Sep 2019 | $13.50 M(+308.8%) | $3.63 M(-74.8%) |
| Jun 2019 | - | $14.40 M(-4.2%) |
| Mar 2019 | - | $15.04 M(-8.3%) |
| Dec 2018 | - | $16.40 M(-13.6%) |
| Sep 2018 | $3.30 M(-15.4%) | $18.98 M(-9.4%) |
| Jun 2018 | - | $20.95 M(+0.4%) |
| Mar 2018 | - | $20.87 M(+23.3%) |
| Dec 2017 | - | $16.93 M(+0.6%) |
| Sep 2017 | $3.90 M(-31.2%) | $16.83 M(+5.6%) |
| Jun 2017 | - | $15.94 M(-4.0%) |
| Mar 2017 | - | $16.61 M(-3.9%) |
| Dec 2016 | - | $17.27 M(-12.4%) |
| Sep 2016 | $5.68 M(-62.6%) | $19.73 M(+8.8%) |
| Jun 2016 | - | $18.13 M(-12.5%) |
| Mar 2016 | - | $20.73 M(+0.6%) |
| Dec 2015 | - | $20.60 M(+3.8%) |
| Sep 2015 | $15.16 M(0.0%) | $19.84 M |
| Sep 2014 | $15.16 M | - |
FAQ
- What is Outlook Therapeutics annual long term assets?
- What is the all time high annual non current assets for Outlook Therapeutics?
- What is Outlook Therapeutics annual non current assets year-on-year change?
- What is Outlook Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly non current assets year-on-year change?
What is Outlook Therapeutics annual long term assets?
The current annual non current assets of OTLK is $1.41 M
What is the all time high annual non current assets for Outlook Therapeutics?
Outlook Therapeutics all-time high annual long term assets is $19.84 M
What is Outlook Therapeutics annual non current assets year-on-year change?
Over the past year, OTLK annual long term assets has changed by +$85.70 K (+6.49%)
What is Outlook Therapeutics quarterly long term assets?
The current quarterly non current assets of OTLK is $1.41 M
What is the all time high quarterly non current assets for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly long term assets is $20.95 M
What is Outlook Therapeutics quarterly non current assets year-on-year change?
Over the past year, OTLK quarterly long term assets has changed by +$111.30 K (+8.59%)